ORAL CAVITY SQUAMOUS CELL CARCINOMA
Clinical trials for ORAL CAVITY SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ORAL CAVITY SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immunotherapy combo tested for head and neck cancer patients
Disease control CompletedThis study tested whether giving the immunotherapy drug durvalumab along with radiation works better than the standard cetuximab plus radiation for people with advanced head and neck cancer who cannot take the usual chemotherapy drug cisplatin. The trial enrolled 196 participants…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:32 UTC
-
New drug combo shows promise for incurable head and neck cancer
Disease control CompletedThis early-phase trial tested a combination of two drugs (IRX-2 regimen and durvalumab) in 19 patients with advanced head and neck cancer that could not be cured with standard treatments. The main goals were to check safety and see if the drugs could boost the immune response ins…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Virtual planning for jaw rebuilds: better results or just hype?
Knowledge-focused CompletedThis study looked at 132 people with oral or throat cancer who needed part of their jaw removed and rebuilt using a bone from their leg. Half had standard surgery, and half had 3D virtual planning before the operation. The main goal was to see if virtual planning improved quality…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 26, 2026 07:35 UTC